Molecular research
Early bench research focused on how molecules bind, where reactions stall, and what those energy barriers looked like in RNA systems.
How the work evolved over time
Guided walkthrough (5–7 min read).
Start at the beginning or jump to any section if you want the short version first.
From lab bench to institutions
This page maps Kanav Jain’s work from lab research to policy. It shows what got in the way at each level and how those problems were addressed.
Start with the overview, then explore the timeline.
Scroll or swipe to move through the timeline.
How this page works
- Use the panel to track focus, obstacles, and outcomes.
- Tap, tab, or hover over nodes to inspect details.
- Prefer the short version? Jump to the quick summaries below.
Scroll Range
2010 → 2025
Main visual
Evolving journey map
Visual shift
Lab work → care teams → institutions
Main challenge
Slow progress → workflow drag → financial risk → admin burden
Interaction
Scroll and select nodes
Four stages, one method.
The same approach is applied at larger and larger scales.
-
2010–2014 · Molecular
Energy landscapes and binding curves
Lab models tracked where molecular reactions slowed or failed.
Example: RNA binding and stalled reaction steps.
Main signal: binding energy and activation barriers.
-
2014–2019 · Clinical
Workflow drag in care delivery
Clinic workflow audits identified delays across queues, handoffs, and forms.
Example: reducing intake steps to save minutes per visit.
Main signal: time-on-task and repeat work.
-
2019–2023 · Defense
Guardrails for frontline clinicians
Financial risk was translated into practical protections and support.
Example: payment protection for first-generation physicians.
Main signal: exposure, volatility, and loss.
-
2023–2025 · Institutional
Policy-scale burden and civic mechanics
Policy analysis traced compliance effort back to funding and mandates.
Example: mapping how new rules add administrative lift.
Main signal: bureaucracy and compliance load.
Static preview
The interactive timeline loads as you scroll (or when motion is enabled).
Use it to see how bottlenecks change across stages.
Stages
At a glance
What to watch at each stage
- What mattered most Binding energy
- What slowed progress Activation barriers
- What changed Entropy shift
Scale
Tiny scale (molecules)
Main challenge
Hard-to-control molecular behavior
Current stage
Molecular research
2012: Focused on why RNA reactions slowed down.
Quick summaries
Clinical friction reduction
Clinical workflow projects reduced avoidable admin steps and queue delays in day-to-day care delivery.
Systemic defense
Later work focused on financial risk and practical safeguards for first-generation physicians.
Institutional mechanics
Recent policy work examined how compliance requirements translate into real operational burden for people and institutions.